Drug
Dihematoporphyrin Ether clinical trials
Also written porfimer sodium and Photofrin.
- studies test it
- 22
- open now
- 0
- in phase 3
- 4
- first study started
- 1995
How studies write it
Studies that test it under each name
Brand
Development codes
Other names
Studies by the year they started
21 studies that test it; most in 1995 (2)
| Year | Studies |
|---|---|
| 1995 | 2 |
| 1999 | 2 |
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 8
- Phase 2
- 9
- Phase 3
- 4
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 20
Roswell Park Cancer Institute (7) · Abramson Cancer Center at Penn Medicine (2) · Concordia Laboratories Inc. (2) · Harry T Whelan, MD (1) · John DeWitt (1) · University of Miami (1) · Samsung Medical Center (1) · Memorial Sloan Kettering Cancer Center (1)
Often tested with
Tested in the same studies.
Gemcitabine (1) · Antineoplastic Agents (1) · Ethiodized Oil (1)
Studies
Open first, then newest update. How each study uses Dihematoporphyrin Ether is read from its arms, and is right about nine times in ten.
Testing it · 22
- Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung CancerCompletedPhase 1/2Roswell Park Cancer InstituteNCT03735095Written as Porfimer Sodium
- Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing SurgeryCompletedPhase 1Roswell Park Cancer InstituteNCT03678350Written as Porfimer Sodium
- Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural MesotheliomaActive, not recruitingPhase 2Abramson Cancer Center at Penn MedicineNCT02153229Written as Photofrin 2.0 mg/kg
- Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerTerminatedPhase 1Roswell Park Cancer InstituteNCT03727061Written as Porfimer Sodium
- Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot StudyStatus unknownEarly Phase 1Taoyuan General HospitalNCT04753918Written as Porfimer sodium
- Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the PleuraTerminatedPhase 2Abramson Cancer Center at Penn MedicineNCT00601848Written as porfimer sodium
- Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung CancerCompletedPhase 1Concordia Laboratories Inc.NCT02916745Written as Porfimer sodium
- Safety of PDT-Photofrin® Prior to Lung SurgeryCompletedPhase 1Concordia Laboratories Inc.NCT03344861Written as Porfimer Sodium
- Photodynamic Therapy (PDT) for Recurrent Pediatric Brain TumorsCompletedPhase 1Harry T Whelan, MDNCT01682746Written as Photofrin (porfimer sodium) & photodynamic therapy.
- Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic CancerCompletedPhase 1John DeWittNCT01770132Written as porfimer sodium
- Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive TractCompletedPhase 2University of MiamiNCT00453336Written as Porfimer Sodium
- Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac CancerStatus unknownPhase 3The First Affiliated Hospital of Henan University of Science and TechnologyNCT02628665Written as photosensitizer(photofrin)
- Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular CarcinomaCompletedNot applicableSamsung Medical CenterNCT01506115Written as Photofrin
- Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or ThroatTerminatedNot applicableRoswell Park Cancer InstituteNCT00530088Written as porfimer sodium
- Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By SurgeryWithdrawnPhase 3Jonsson Comprehensive Cancer CenterNCT00253617Written as porfimer sodium
- Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00003923Written as porfimer sodium
- Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by SurgeryCompletedPhase 3University College, LondonNCT00513539Written as porfimer sodium
- Porfimer Sodium in Diagnosing Patients With Head and Neck CancerCompletedPhase 2Roswell Park Cancer InstituteNCT00002964Written as porfimer sodium
- Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder CancerCompletedPhase 1/2North Florida/South Georgia Veterans Health SystemNCT00322699Written as Photofrin
- Photodynamic Therapy in Treating Patients With Early Esophageal CancerCompletedPhase 2Roswell Park Cancer InstituteNCT00002935Written as porfimer sodium
See all 22 studies that test Dihematoporphyrin Ether →
Given in every arm · 3 — Dihematoporphyrin Ether is usual care beside what is tested
- Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural DiseaseTerminatedPhase 1Roswell Park Cancer InstituteNCT04836429Written as Porfimer Sodium
- Photodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyWithdrawnNot applicableOhio State University Comprehensive Cancer CenterNCT02106559Written as porfimer sodium
- Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck CancerTerminatedPhase 2Roswell Park Cancer InstituteNCT02068157Written as Porfimer Sodium
Codes
What other systems call Dihematoporphyrin Ether · ClinicalTrials.gg INT008584
- MeSH (NLM) D017323Dihematoporphyrin EtherOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017323 | Dihematoporphyrin Ether | One source ClinicalTrials.gov |
Also registered as bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether (UNII 625J2HS54G · RxNorm 23066), porfimer (UNII M15H03K69B · RxNorm 333848) and porfimer sodium (UNII Y3834SIK5F · RxNorm 333848).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.